SmallCaps
ASX:CMPHealth Care Equipment & ServicesHealth Care Equipment

Compumedics Ltd

$0.255
Day Range
$0.255 – $0.255
52 Week Range
$0.240 – $0.450
Volume
0.00
Avg Volume (10D)
77.20K
Market Cap
$50.94M

Price Chart

OHLC · volume · moving averages

$0.255-$0.105 (-29.17%)over 6M
Hi$0.450Lo$0.240
Price-sensitive newsVolumePrev close · 52W range

Market Statistics

Today's trading range

Open
$0.255
Previous Close
$0.255
Day High
$0.255
Day Low
$0.255
52 Week High
$0.450
52 Week Low
$0.240

Valuation

Fundamental multiples

Market Cap
50.94M
Shares Outstanding
199.76M
P/E Ratio (TTM)
471.70
Price to Book
2.14

Trading Activity

Volume & order book

Volume
0.00
Value Traded
0.00
Bid
$0.255 × 5,000
Ask
$0.260 × 1,000

Performance

Returns across timeframes

1 Day
0.00%
5 Day
2.04%
13 Week
-15.25%
52 Week
2.04%
YTD
-25.37%

Technical Indicators

Momentum & moving averages

RSI (14)
44.34
50-Day SMA
$0.274
200-Day SMA
$0.316

— From the desk

Latest News

Compumedics Looks to Turn the Corner after Record Sales And Growth in FY25
Biotechnology

Compumedics Looks to Turn the Corner after Record Sales And Growth in FY25

Compumedics (ASX: CMP) has marked a strategic turning point in its development after posting record sales and profitable growth for the 2025 financial year. The company racked up $63.4 million in sales for the period, representing a growth of 22% on the previous year. Its EBITDA increased to approximately $3m, returning Compumedics to profitability and […]

Compumedics reaches $20m in Chinese MEG sales with latest university contract
Biotechnology

Compumedics reaches $20m in Chinese MEG sales with latest university contract

Brain research technologies specialist Compumedics (ASX: CMP) has reached $20 million in sales for its magnetoencephalography (MEG) system in China. The latest $5.7m contract from Hangzhou Normal University follows the successful installation of a MEG system at Tianjin Normal University and further orders from Tsinghua and Tianjin universities. MEG is a neuroimaging technique for mapping […]

Compumedics eyes US market with Somfit sleep diagnostic device
Technology

Compumedics eyes US market with Somfit sleep diagnostic device

Brain research technology specialist Compumedics (ASX: CMP) has achieved a major breakthrough with the planned distribution of its Somfit sleep assist system, with the Food & Drug Administration (FDA) clearing the device to be marketed in the United States. Compumedics is targeting the multi-million dollar sleep market in the US with the Somfit technology, which […]

US FDA approves Compumedics’ MEG neuroimaging technology enabling insurers to be billed
Biotechnology

US FDA approves Compumedics’ MEG neuroimaging technology enabling insurers to be billed

Compumedics (ASX: CMP) has collared US Food and Drug Administration approval for its neuroimaging technology, enabling insurers to be billed for the scan. On Friday, the FDA officially granted 510(K) clearance to Compumedics for its Orion LifeSpan Magnetoencephalography (MEG) single Dewar system. Compumedics’ MEG is a neuroimaging technique that maps brain activity by recording magnetic […]